cell surface receptor

New preclinical research shows that cannabinoid cell surface receptor CB1 plays a tumor-suppressing role in human colorectal cancer, scientists report in the Aug. 1 edition of the journal Cancer Research.

Squamous cell cancers of the head and neck that express a cell surface receptor, called CCR7, are less likely to respond to current therapies.

Combining drugs that block this receptor with existing agents might improve patient outcomes.